title: Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator.
abstract: A group of polyunsaturated fatty acids called conjugated linoleic acids (CLAs) are found in ruminant products, where the most common isomers are cis9, trans11 (c 9,t11) and trans10, cis12 (t10,c12) CLA. A crude mixture of these isomers has been shown in animal studies to alter body composition by a reduction in body fat mass as well as an increase in lean body mass, with the t10,c12 isomer having the most pronounced effect. The objective of this study was to establish the molecular mechanisms by which t10,c12 CLA affects lipid accumulation in adipocytes. We have shown that t10,c12 CLA prevents lipid accumulation in human and mouse adipocytes at concentrations as low as 5 microM and 25 microM, respectively. t10,c12 CLA fails to activate peroxisome proliferator-activated receptor gamma (PPARgamma) but selectively inhibits thiazolidinedione-induced PPARgamma activation in 3T3-L1 adipocytes. Treatment of mature adipocytes with t10,c12 CLA alone or in combination with Darglitazone down-regulates the mRNA expression of PPARgamma as well as its target genes, fatty acid binding protein (aP2) and liver X receptor alpha (LXRalpha). Taken together, our results suggest that the trans10, cis12 CLA isomer prevents lipid accumulation in adipocytes by acting as a PPARgamma modulator.
authors.affiliation: Institute for Nutrition Research, University of Oslo, N-0316 Oslo, Norway.
authors.forename: Linda
authors.initials: L
authors.lastname: Granlund
authors.forename: Lene K
authors.initials: LK
authors.lastname: Juvet
authors.forename: Jan I
authors.initials: JI
authors.lastname: Pedersen
authors.forename: Hilde I
authors.initials: HI
authors.lastname: Nebb
mesh_terms: D033962:Adaptor Protein Complex 2 / Q000235:genetics; D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism*; D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D004268:DNA-Binding Proteins; D015536:Down-Regulation / Q000187:drug effects; D004789:Enzyme Activation; D006801:Humans; D044243:Linoleic Acids, Conjugated / Q000494:pharmacology*; D000071518:Liver X Receptors; D051379:Mice; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism*; D045162:Thiazolidinediones / Q000494:pharmacology; D013997:Time Factors; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D033962:Adaptor Protein Complex 2; D004268:DNA-Binding Proteins; D044243:Linoleic Acids, Conjugated; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; C000605214:Nr1h3 protein, mouse; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors; D014280:Triglycerides; C089948:darglitazone